Re-assessment of the Actual Benefit of all medicines based on
-
Clinical Benefit
Substantial
The actual benefit of this proprietary medicinal product in this indication remains substantial.
Insufficient
The actual benefit of this proprietary medicinal product in this indication remains insufficient in the sub-population of patients with risk factors for a cardiovascular event.
Listen
